Text Size

Burden, Belonging, and Response to Pain in Veterans

This study is currently recruiting participants.
Verified July 2012 by VA Eastern Colorado Health Care System
Sponsor:
Information provided by (Responsible Party):
VA Eastern Colorado Health Care System
ClinicalTrials.gov Identifier:
NCT01507675
First received: December 9, 2011
Last updated: July 25, 2012
Last verified: July 2012
History of Changes
  Purpose

The primary purpose of the current study is to rigorously test the psychometric properties of the INQ-12 and ACSS (Van Orden et al., 2008) in Veterans, something which has not been done to date. Factor structure, internal consistency, convergent and discriminant validity will all be assessed. Secondary goals are to determine if burdensomeness, failed belongingness, and acquired capability are distinct versus overlapping constructs and whether or not values mediate the relationship between reasons for living and suicide risk. Lastly, the inclusion of the Beck Scale for Suicidal Ideation (BSS) allows us to analyze participants' responses to explore whether or not participants can be grouped into those who want to die by suicide because they want to escape their problems and those who want to die to influence other people.


Condition
Suicide

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Burden, Belonging, and Response to Pain in Veterans

Resource links provided by NLM:

MedlinePlus related topics: Suicide
U.S. FDA Resources

Further study details as provided by VA Eastern Colorado Health Care System:

Primary Outcome Measures:
  • Internal consistency reliability. [ Time Frame: two years ] [ Designated as safety issue: No ]
    The internal consistency reliability statistics will be calculated for all study variables to confirm the measures are reliable.

  • Convergent validity. [ Time Frame: two years ] [ Designated as safety issue: No ]
    Convergent validity of the Interpersonal Needs Questionnaire (INQ) will be determined by examining the correlation between it and the other study measures.

  • Convergent validity. [ Time Frame: two years ] [ Designated as safety issue: No ]
    Convergent validity of the acquired capability of suicide scale (ACSS) will be determined by correlating it with all other measures.


Secondary Outcome Measures:
  • Discriminant validity. [ Time Frame: two years ] [ Designated as safety issue: No ]
    Discriminant validity of the interpersonal needs questionnaire (INQ) will be determined by examining correlations with measures of unrelated constructs.

  • Suicide risk. [ Time Frame: two years ] [ Designated as safety issue: No ]
    Examine the effects of scores on the SLP on the relationship between reasons that people have for living and the potential for engaging in at-risk behavior.

  • Discriminant validity [ Time Frame: two years ] [ Designated as safety issue: No ]
    Examine the discriminant validity of the acquired capability for suicide scale (ACSS) by examining correlations between it and measures of unrelated constructs.


Estimated Enrollment: 530
Study Start Date: October 2011
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Military Veterans
Participants will be recruited from the Denver VA Medical Center (DVAMC), regardless of clinic.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Participants will be recruited from all individuals eligible to receive care at the Denver VA Medical Center (DVAMC), regardless of clinic.

Criteria

Inclusion Criteria:

  • Military veteran
  • 18 or older
  • Ability to respond to questions regarding the informed consent

Exclusion Criteria:

  • Active-duty military
  • Non-English speaking
  • Inability to respond to questions regarding the informed consent procedure
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01507675

Contacts
Contact: James L Pease, MSW 303-329-4408 ext 305

Locations
United States, Colorado
Va Visn 19 Mirecc Recruiting
Denver, Colorado, United States, 80220
Contact: James L Pease, MSW     303-329-4408 ext 305        
Sub-Investigator: Lisa M Brenner, PhD            
Sub-Investigator: Nazanin Bahraini, PhD            
Sub-Investigator: Theresa Hernandez, PhD            
Sub-Investigator: Bridget Bulman, PhD            
Sub-Investigator: Pamela Staves, RN, MS, NP            
Sub-Investigator: James L Pease, MSW            
Sponsors and Collaborators
VA Eastern Colorado Health Care System
Investigators
Principal Investigator: Peter M. Gutierrez, PhD Clinical Research Psychologist VA VISN 19 MIRECC
  More Information

Additional Information:
The mission of the VISN 19 MIRECC is to study suicide with the goal of reducing suicidality in the veteran population.  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: VA Eastern Colorado Health Care System
ClinicalTrials.gov Identifier: NCT01507675     History of Changes
Other Study ID Numbers: COMIRB 11-0948
Study First Received: December 9, 2011
Last Updated: July 25, 2012
Health Authority: United States: Federal Government

Keywords provided by VA Eastern Colorado Health Care System:
suicide
psychometric properties
military
veterans
Interpersonal needs questionnaire
 Acquired capability for suicide
mental health
Survey of Life Principles
Risk assessment

Additional relevant MeSH terms:
Suicide
Self-Injurious Behavior
Behavioral Symptoms

ClinicalTrials.gov processed this record on May 16, 2013